跳至主要内容
临床试验/NCT02094950
NCT02094950已完成1 期

Acupuncture Feasibility Trial for Dyspnea in Lung Cancer

Abramson Cancer Center at Penn Medicine2 个研究点 分布在 1 个国家目标入组 12 人开始时间: 2014年3月最近更新:
适应症
干预措施

试验速览

阶段
1 期
状态
已完成
入组人数
12
试验地点
2
主要终点
Dyspnea

研究概览

简要总结

This is a single arm clinical trial to establish the feasibility of conducting a clinical trial of acupuncture in reducing dyspnea among lung cancer survivors who have completed chemoradiotherapy. Twelve subjects with dyspnea will be recruited to this clinical trial. Up to 10 sessions of acupuncture will be delivered over the course of 8-10 weeks. The primary outcome will be dyspnea as measured by the English version of the Cancer Dyspnea Scale at the completion of the intervention.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Supportive Care

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of Lung Cancer (Non small cell and small cell both eligible)
  • Completion of concurrent CRT at least 6 months prior to randomization.
  • Dyspnea which worsened after Chemoradiotherapy, leading to a ATS dyspnea score greater than or equal to 2 (Walks slower than people of the same age on the level because of breathlessness or has to stop for breath when walking at own pace on level)
  • Ability to understand written English -Willingness to adhere to all study-related procedures
  • Age 18 years old
  • ECOG Performance Status 1-3

排除标准

  • Current receipt of therapy for treatment related pneumonitis for 3 weeks.
  • Surgical resection of this LC (lobectomy or pneumonectomy)
  • Another organic cause of dyspnea necessitating treatment (eg pleural effusion appropriate for thoracentesis, rapidly progressive intrathoracic recurrence, symptomatic pulmonary embolus after CRT, untreated anemia with hemoglobin8 g/dL)
  • Current bleeding disorder by history
  • Life expectancy of 12 weeks, as assessed by primary oncologist

研究组 & 干预措施

Lung Cancer Patient with Dyspnea

Experimental

干预措施: Acupuncture (Procedure)

结局指标

主要结局

Dyspnea

时间窗: 10 weeks

次要结局

未报告次要终点

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验